
Lupin Limited has informed the Exchange regarding a press release dated Jun 23, 2023, titled "Lupin Launches Rufinamide Oral Suspension in the United States.".
Filed with NSE ·

Lupin Limited has informed the Exchange regarding a press release dated Jun 23, 2023, titled "Lupin Launches Rufinamide Oral Suspension in the United States.".
6ix hasn’t read this filing yet.
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin